Cargando…
A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer
BACKGROUND: The association between the survival or efficacy of chemotherapy and the Lauren subtype of gastric cancer (GC) remains unclear. We aimed to clarify whether patients with different Lauren subtypes have different survival after treatment with systemic chemotherapy: intestinal gastric cance...
Autores principales: | Wang, Kunning, Li, Enxiao, Busuttil, Rita A., Kong, Joseph C., Pattison, Sharon, Sung, Joseph J. Y., Yu, Jun, El-Omar, Emad M., Simpson, Julie A., Boussioutas, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378722/ https://www.ncbi.nlm.nih.gov/pubmed/32754227 http://dx.doi.org/10.1177/1758835920930359 |
Ejemplares similares
-
Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer
por: Pattison, Sharon, et al.
Publicado: (2017) -
ASO Author Reflections: Consideration of a Modified Classification System for Gastric Cancer Based on Lauren Subtypes
por: Zhao, Lin-Yong, et al.
Publicado: (2018) -
Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology
por: Cisło, Magdalena, et al.
Publicado: (2018) -
CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia
por: Koulis, Athanasios, et al.
Publicado: (2022) -
Gastric Intestinal Metaplasia: Challenges and the Opportunity for Precision Prevention
por: Tjandra, Douglas, et al.
Publicado: (2023)